Production of Tumour Necrosis Factor-a, Interferon-y and lnterleukin-2 by Peripheral Blood Mononuclear Cells of Subjects Suffering from Rheumatoid Arthritis

References

• Vaughan J. Rheumatoid arthritis: evidence for a defect in T cell function. Hospital Practice 1984; 19: 101–7
   Web of Science ®Google Scholar
• Abdou N I, Lindsley H B, Racela L S, Pascual E, Hassanein K M. Suppressor cell disfunction and anti-suppressor cell antibody in active early rheumatoid arthritis. J Rheumatol 1981; 9: 9–18
   Google Scholar
• Chattopadhyay C, Chattopadhyay H, Natvig J B, Michaelsen T E, Mellbye O J. Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol 1979; 10: 309–16
   PubMed Web of Science ®Google Scholar
• Depper J M, Bluestein H G, Zvaifler N J. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 1981; 127: 1899–1902
   PubMed Web of Science ®Google Scholar
• Strelkauskas A J, Callery R T, McDowell J, Borel Y, Schlossman S F. Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci USA 1978; 75: 5150–4
   PubMed Web of Science ®Google Scholar
• Tosato G, Steinberg A D, Blaese R M. Defective EBV specific T-cell function in rheumatoid arthritis. N Engl J Med 1981; 305: 1238–43
   PubMed Web of Science ®Google Scholar
• Al-Balaghi S, Strom H, Moller E. B-cell differentiation factor in synovial fluids of patients with rheumatoid arthritis. Immunol Rev 1984; 78: 7–23
   PubMed Web of Science ®Google Scholar
• Pardo I, Levinson A I. Circulating immunoglobulin secreting cells in rheumatoid arthritis. Clin Immunol Immunopathol 1983; 29: 29–34
   Google Scholar
• Krane S M, Simon L S. Rheumatoid arthritis: clinical features and pathogenetic mechanisms. Med Clin North Am 1986; 70: 263–84
   PubMed Web of Science ®Google Scholar
• Gillis S, Ferm M M, Ou W, Smith K A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978; 120: 2027–32
   PubMed Web of Science ®Google Scholar
• Atkins G J, Johnson M D, Westmacott L M, Burke D C. Induction of interferon in chick cells by temperature-sensitive mutants of sindbis virus. J Gen Virol 1974; 25: 381–90
   Google Scholar
• Yamazaki S, Onishi E, Enami K, Natori K, Kohase M, Sakamoto H, Tanouchi M, Hayashi H. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Japan J Med Sci Biol 1986; 39: 105–18
   PubMedGoogle Scholar
• Ropes M W, Bennett E A, Cobb S, Jacox R, Jessar R. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Tice R R, Schneider E L, Kram D, Thorne P. Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin. J Exp Med 1979; 149: 1029–41
   PubMed Web of Science ®Google Scholar
• Greenwood F, Hunter W, Glover J. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–24
   PubMed Web of Science ®Google Scholar
• Franchimont P, Bouffioux C h, Reuter A, Rigo-Betz C h, Vrindts-Gevaert Y, Jaspar J M, Lecomte-Yerna M J. Radioimmunoassay of prostatic acid phosphatase: validation and clinical application. Int J Cancer 1983; 1: 149–55
   Google Scholar
• Reuter A, Bernier J, Vrindts-Gevaert Y, Gathy-Meuleman R, Malaise M, Fiers W, Franchimont P. Radioimmunoassay of interferon-gamma. Its clinical application, Interferon Research [in press].
   Google Scholar
• Cathely G, Dougados B, Amor B, Fradelizi D. Interleukine 2 et polyarthrite rhumatoi'de. Rev Rhum 1984; 51: 251–6
   Google Scholar
• Emery P, Panayi G S, Nouri M E. Interleukin 2 reverses deficient cell-mediated immune response in rheumatoid arthritis. Clin Exp Immunol 1984; 57: 123–8
   PubMed Web of Science ®Google Scholar
• McKenna R M, Ofosu-Appiah W, Warrington R J, Wilkins J A. Interleukin-2 production and responsiveness in active and inactive rheumatoid arthritis. J Rheumatol 1986; 13: 28–33
   PubMed Web of Science ®Google Scholar
• Miyasaka N, Nakamura T, Russell I J, Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 31: 109–16
   PubMedGoogle Scholar
• Lemm G, Warnatz H. Evidence for enhanced interleukin 2 (IL2) secretion and IL2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis. Clin Exp Immunol 1986; 64: 71–7
   PubMed Web of Science ®Google Scholar
• Ridley M G, Panayi G S, Nicholas N S, Murphy J. Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma interferon. Clin Exp Immunol 1986; 63: 587–93
   PubMed Web of Science ®Google Scholar
• Combe B, Pope R M, Fishbach L M, Dennell B, Baron S, Talal N. Interleukin 2 in rheumatoid arthritis: production of and response to interleukin 2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 1985; 59: 520–31
   PubMed Web of Science ®Google Scholar
• Hasler F, Bluestein H G, Zvaifler N J, Epstein L B. Analysis of the defect responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma-interferon production in response to autologous stimulation. J Exp Med 1983; 157: 173–81
   PubMed Web of Science ®Google Scholar
• Tsokos G C, Boumpas D R, Smith J Y, Djeu S MY, Balow J E, Rook A H. Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum 1986; 29: 1210–5
   PubMedGoogle Scholar
• Ceuppens J L, Robaeys G, Verdickt W, Vertessen S, Deckmyn H, Dequeker J. Immunomodulatory effects of treatment with Naproxen in patients with rheumatic disease. Arthritis Rheum 1986; 29: 305–11
   PubMedGoogle Scholar
• Rola-Pleszczynski M, Chavailiaz P A, Lemaire I. Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins Leukotrienes Med 1986; 23: 207–10
   PubMedGoogle Scholar
• Cathely G, Amor B, Fournier C. Defective IL2 production in active rheumatoid arthritis. Regulation by radiosensitive suppressor cells. Clin Rheumatol 1986; 5: 482–92
   PubMed Web of Science ®Google Scholar
• Kass E, Waalen K, Forre O. Rheumatoid synovial T cells are activated in vivo. Inhibition of the spontaneous interleukin 2-driven proliferation by anti-Tac and cyclosporin. Clin Exp Rheuma 1987; 5(suppl2)58
   Google Scholar